See the latest Coronavirus Information including testing sites, visitation restrictions, appointments and scheduling, and more.
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Perelman Center for Advanced Medicine
West Pavilion, 4th Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Joanna M Rhodes, Vincent A LoRe, Anthony R Mato, Elise A Chong, Jacqueline C Barrientos, James N Gerson, Stefan K Barta, Daniel J Landsburg, Sunita Dwivedy Nasta, Jakub Svoboda, Alison W Loren, Stephen J Schuster.: Ibrutinib-associated Arthralgias/Myalgias in Patients with Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes Clin Lymphoma Myeloma Leuk 20 (7): 438-444,2020.
Mitchell E Hughes, Daniel J Landsburg, Daniel J Rubin, Stephen J Schuster, Jakub Svoboda, James N Gerson, Esin Namoglu, Sunita D Nasta.: Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma With Venetoclax: A Single-Center Evaluation of Off-Label Use Clin Lymphoma Myeloma Leuk
19 (12): 791-798,2019.
James N Gerson, Stefan K Barta.: Mantle Cell Lymphoma: Which Patients Should We Transplant? Curr Hematol Malig Rep
14 (4): 239-246,2019.
James N. Gerson, Elizabeth Handorf, Diego Villa, Alina S. Gerrie: Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era J Clin Oncol 37 (6): 471-480,2019.
Gerson JN, Barta SK: Choice of Induction Regimen in the Treatment of Mantle Cell Lymphoma Across 25 Academic Medical Centers Fox Chase Research Symposium, Philadelphia PA. : 2018.
James N Gerson, Chethan Ramamurthy, Hossein Borghaei.: Managing adverse effects of immunotherapy Clin Adv Hematol Oncol
16 (5): 364-374,2018.
Gerson JN, Handorf E, Villa D, Gerrie AS, Chapani P, Li S, Medeiros LJ, Wang M, Cohen JB, Calzada O, Churnetski M, Hill BT, Sawalha Y, Hernandez-Ilizaliturri FJ, Kothari S, Vose J, Bast M, Fenske TS, Narayana Rao Gari S, Maddocks KJ, Bond D, Bachanova V, Kolla B, Chavez J, Shah B, Lansigan F, Burns T, Donovan AM, Wagner N, Messmer M, Mehta A, Anderson JK, Reddy N, Kovach A, Landsburg DJ, Glenn M, Inwards DJ, Ristow K, Karmali R, Kaplan JB, Caimi PF, Rajguru S, Evens A, Klein A, Umyarova E, Pulluri B, Amengual JE, Lue JK, Diefenbach C, Barta SK: Outcome of Young Patients with Blastoid Variant Mantle Cell Lymphoma: An Analysis of 138 Patients AACR Malignant Lymphoma, Boston MA Abstract 131 : 2018.
Gerson JN, Witteles RN, Chang DT, Beygui RE, Iagara AH, Kunz PL.: Carcinoid Syndrome Complicating a Pancreatic Neuroendocrine Tumor: A Case Report. Pancreas. 46 (10): 1381-85,2017.
Gerson JN, Dotan E.: “Adjuvant Chemotherapy in the Treatment of Colon Cancer,” Hematology-Oncology Board Review Manuel : 2017.
Daniel J Landsburg, Marissa K Falkiewicz, Joseph Maly, Kristie A Blum, Christina Howlett, Tatyana Feldman, Anthony R Mato, Brian T Hill, Shaoying Li, L Jeffrey Medeiros, Pallawi Torka, Francisco Hernandez-Ilizaliturri, Nishitha M Reddy, Arun Singavi, Timothy S Fenske, Julio C Chavez, Jason B Kaplan, Amir Behdad, Adam M Petrich, Martin A Bast, Julie M Vose, Adam J Olszewski, Cristiana Costa, Frederick Lansigan, James N Gerson, Stefan K Barta, Oscar Calzada, Jonathon B Cohen, Jennifer K Lue, Jennifer E Amengual, Xavier Rivera, Daniel O Persky, David J Peace, Sunita Nathan, Ryan D Cassaday.: “Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission,” J Clin Oncol
35 (20): 2260-2267,2017.
12 South PCAM 12-1813400 Civic Center Blvd
Patient appointments: 800-789-7366